vs
Side-by-side financial comparison of ACADIA PHARMACEUTICALS INC (ACAD) and Wingstop Inc. (WING). Click either name above to swap in a different company.
ACADIA PHARMACEUTICALS INC is the larger business by last-quarter revenue ($284.0M vs $183.7M, roughly 1.5× Wingstop Inc.). ACADIA PHARMACEUTICALS INC runs the higher net margin — 96.3% vs 16.3%, a 80.1% gap on every dollar of revenue. On growth, ACADIA PHARMACEUTICALS INC posted the faster year-over-year revenue change (9.4% vs 7.4%). Over the past eight quarters, ACADIA PHARMACEUTICALS INC's revenue compounded faster (17.5% CAGR vs 8.6%).
Acadia Pharmaceuticals Inc. is a biopharmaceutical company headquartered in Del Mar, San Diego, California.
Wingstop Inc. is an American international fast food chain that primarily sells buffalo wings. Wingstop locations are decorated with a 1930s and 1940s pre-jet aviation theme.
ACAD vs WING — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $284.0M | $183.7M |
| Net Profit | $273.6M | $29.9M |
| Gross Margin | 90.8% | 86.5% |
| Operating Margin | 6.1% | 27.4% |
| Net Margin | 96.3% | 16.3% |
| Revenue YoY | 9.4% | 7.4% |
| Net Profit YoY | 90.3% | — |
| EPS (diluted) | $1.61 | $1.08 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $183.7M | ||
| Q4 25 | $284.0M | $175.7M | ||
| Q3 25 | $278.6M | $175.7M | ||
| Q2 25 | $264.6M | $174.3M | ||
| Q1 25 | $244.3M | $171.1M | ||
| Q4 24 | $259.6M | $161.8M | ||
| Q3 24 | $250.4M | $162.5M | ||
| Q2 24 | $242.0M | $155.7M |
| Q1 26 | — | $29.9M | ||
| Q4 25 | $273.6M | $26.8M | ||
| Q3 25 | $71.8M | $28.5M | ||
| Q2 25 | $26.7M | $26.8M | ||
| Q1 25 | $19.0M | $92.3M | ||
| Q4 24 | $143.7M | $26.8M | ||
| Q3 24 | $32.8M | $25.7M | ||
| Q2 24 | $33.4M | $27.5M |
| Q1 26 | — | 86.5% | ||
| Q4 25 | 90.8% | — | ||
| Q3 25 | 92.2% | — | ||
| Q2 25 | 92.2% | — | ||
| Q1 25 | 91.7% | — | ||
| Q4 24 | 91.6% | 85.6% | ||
| Q3 24 | 92.5% | 85.0% | ||
| Q2 24 | 92.5% | 85.4% |
| Q1 26 | — | 27.4% | ||
| Q4 25 | 6.1% | 26.7% | ||
| Q3 25 | 12.8% | 27.9% | ||
| Q2 25 | 12.2% | 25.9% | ||
| Q1 25 | 7.9% | 22.4% | ||
| Q4 24 | 59.1% | 25.9% | ||
| Q3 24 | 12.6% | 24.5% | ||
| Q2 24 | 12.6% | 26.5% |
| Q1 26 | — | 16.3% | ||
| Q4 25 | 96.3% | 15.2% | ||
| Q3 25 | 25.8% | 16.2% | ||
| Q2 25 | 10.1% | 15.4% | ||
| Q1 25 | 7.8% | 53.9% | ||
| Q4 24 | 55.4% | 16.5% | ||
| Q3 24 | 13.1% | 15.8% | ||
| Q2 24 | 13.8% | 17.7% |
| Q1 26 | — | $1.08 | ||
| Q4 25 | $1.61 | $0.99 | ||
| Q3 25 | $0.42 | $1.02 | ||
| Q2 25 | $0.16 | $0.96 | ||
| Q1 25 | $0.11 | $3.24 | ||
| Q4 24 | $0.86 | $0.91 | ||
| Q3 24 | $0.20 | $0.88 | ||
| Q2 24 | $0.20 | $0.93 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $177.7M | $128.8M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $1.2B | — |
| Total Assets | $1.6B | $648.9M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $128.8M | ||
| Q4 25 | $177.7M | $196.6M | ||
| Q3 25 | $258.0M | $237.6M | ||
| Q2 25 | $253.6M | $227.9M | ||
| Q1 25 | $217.7M | $251.4M | ||
| Q4 24 | $319.6M | $315.9M | ||
| Q3 24 | $155.1M | $84.0M | ||
| Q2 24 | $177.1M | $96.7M |
| Q1 26 | — | — | ||
| Q4 25 | — | $1.2B | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $1.2B | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q1 26 | — | — | ||
| Q4 25 | $1.2B | $-736.8M | ||
| Q3 25 | $917.3M | $-702.6M | ||
| Q2 25 | $822.4M | $-686.0M | ||
| Q1 25 | $765.2M | $-715.0M | ||
| Q4 24 | $732.8M | $-675.6M | ||
| Q3 24 | $577.2M | $-447.5M | ||
| Q2 24 | $516.7M | $-437.5M |
| Q1 26 | — | $648.9M | ||
| Q4 25 | $1.6B | $693.4M | ||
| Q3 25 | $1.3B | $721.0M | ||
| Q2 25 | $1.2B | $708.3M | ||
| Q1 25 | $1.1B | $696.8M | ||
| Q4 24 | $1.2B | $716.2M | ||
| Q3 24 | $976.9M | $484.8M | ||
| Q2 24 | $914.1M | $451.8M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-48.7M | — |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | -0.18× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $-48.7M | $57.3M | ||
| Q3 25 | $74.3M | $63.9M | ||
| Q2 25 | $64.0M | $6.6M | ||
| Q1 25 | $20.3M | $25.3M | ||
| Q4 24 | $40.4M | $7.7M | ||
| Q3 24 | $63.2M | $69.0M | ||
| Q2 24 | $25.0M | $36.2M |
| Q1 26 | — | — | ||
| Q4 25 | — | $34.5M | ||
| Q3 25 | $73.9M | $61.7M | ||
| Q2 25 | — | $-7.8M | ||
| Q1 25 | — | $17.3M | ||
| Q4 24 | — | $-8.6M | ||
| Q3 24 | $63.2M | $54.9M | ||
| Q2 24 | — | $25.9M |
| Q1 26 | — | — | ||
| Q4 25 | — | 19.6% | ||
| Q3 25 | 26.5% | 35.1% | ||
| Q2 25 | — | -4.5% | ||
| Q1 25 | — | 10.1% | ||
| Q4 24 | — | -5.3% | ||
| Q3 24 | 25.2% | 33.8% | ||
| Q2 24 | — | 16.6% |
| Q1 26 | — | — | ||
| Q4 25 | — | 13.0% | ||
| Q3 25 | 0.1% | 1.3% | ||
| Q2 25 | — | 8.2% | ||
| Q1 25 | — | 4.7% | ||
| Q4 24 | — | 10.1% | ||
| Q3 24 | 0.0% | 8.7% | ||
| Q2 24 | — | 6.6% |
| Q1 26 | — | — | ||
| Q4 25 | -0.18× | 2.14× | ||
| Q3 25 | 1.03× | 2.24× | ||
| Q2 25 | 2.40× | 0.25× | ||
| Q1 25 | 1.07× | 0.27× | ||
| Q4 24 | 0.28× | 0.29× | ||
| Q3 24 | 1.93× | 2.68× | ||
| Q2 24 | 0.75× | 1.32× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ACAD
| Nuplazid | $174.4M | 61% |
| Daybue | $109.6M | 39% |
WING
| Royalty revenue, franchise fees and other | $87.5M | 48% |
| Advertising fees | $63.3M | 34% |
| Company-owned restaurant sales | $33.0M | 18% |
